Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c1131
Identifier NCT05535946
Trial Title ABTECT - Maintenance
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: ABX464|DRUG: Placebo
Participant Information
Sponsor Abivax S.A.
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2023-01-16
Primary Completion Date 2026-04
Completion Date 2030-05